These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21162905)

  • 1. [Somatostatin enhanced anti-tumor effect of doxorubicin on gallbladder cancer cells through the regulation of intracellular drug concentration].
    Gong W; Qin YY; Li SG; Quan ZW; Li JY; Zhuang PY; Wan ZW
    Zhonghua Yi Xue Za Zhi; 2010 Oct; 90(38):2718-22. PubMed ID: 21162905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
    Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
    Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism research in somatostatin reverting the chemosensitivity of GBC-SD cell line].
    Qin YY; Li JY; Li SG; Yue JN; Quan ZW
    Zhonghua Wai Ke Za Zhi; 2008 Mar; 46(5):381-3. PubMed ID: 18785538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin: cell cycle modulation plus target enzyme up-regulation.
    Quan ZW; Yang Y; Li JY; Gong W; Qin YY; Li SG
    Biomed Pharmacother; 2010 Sep; 64(7):451-7. PubMed ID: 20359855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin elevates topoisomerase II alpha and enhances the cytotoxic effect of doxorubicin on gallbladder cancer cells.
    Quan ZW; Yue JN; Li JY; Qin YY; Guo RS; Li SG
    Chemotherapy; 2008; 54(6):431-7. PubMed ID: 18824850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic action of doxorubicin and sulindac in human cervix carcinoma cells - studies on possible mechanisms.
    Gruber BM; Bubko I; Krzyszton-Russjan J; Anuszewska EL
    Med Sci Monit; 2010 Jan; 16(1):BR45-51. PubMed ID: 20037485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma.
    Li JY; Quan ZW; Zhang Q; Liu JW
    BMC Cancer; 2007 Jul; 7():125. PubMed ID: 17617924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. siRNA Targeting of MDR1 Reverses Multidrug Resistance in a Nude Mouse Model of Doxorubicin-resistant Human Hepatocellular Carcinoma.
    Yang H; Ding R; Tong Z; Huang J; Shen L; Sun YU; Liao J; Yang Z; Hoffman RM; Wang C; Meng X
    Anticancer Res; 2016 Jun; 36(6):2675-82. PubMed ID: 27272776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
    Fan YZ; Fu JY; Zhao ZM; Chen CQ
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effect of a novel cytotoxic somatostatin analogue AN-162 on experimental glioblastoma.
    Pozsgai E; Schally AV; Halmos G; Rick F; Bellyei S
    Horm Metab Res; 2010 Oct; 42(11):781-6. PubMed ID: 20665426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of tetrandrine on the doxorubicin-induced expression of mdr1 gene in K562 cells].
    Lu XJ; Xu WL; Luo WJ; Wang FC; Chen QY
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):468-71. PubMed ID: 19035180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AZT and emodin exhibit synergistic growth-inhibitory effects on K562/ADM cells by inducing S phase cell cycle arrest and suppressing MDR1 mRNA/p-gp protein expression.
    Chen P; Liu Y; Sun Y; Chen C; Qi Y; Zhang Y
    Pharm Biol; 2013 Dec; 51(12):1586-91. PubMed ID: 24004004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
    Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
    J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
    Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid inhibits overexpression of P-glycoprotein induced by doxorubicin in HepG2 cells.
    Komori Y; Arisawa S; Takai M; Yokoyama K; Honda M; Hayashi K; Ishigami M; Katano Y; Goto H; Ueyama J; Ishikawa T; Wakusawa S
    Eur J Pharmacol; 2014 Feb; 724():161-7. PubMed ID: 24370495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells.
    Gatouillat G; Magid AA; Bertin E; El btaouri H; Morjani H; Lavaud C; Madoulet C
    Phytomedicine; 2015 Dec; 22(13):1186-94. PubMed ID: 26598918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.